$MOH (Molina Healthcare, Inc.)

$MOH {{ '2015-11-30T23:00:04+0000' | timeago}} • Announcement

$MOH said that it has agreed to acquire Better Health Network in Cook County, Illinois and assume certain assets related to the operation of Better Health's Medicaid business. $MOH will fund the deal with available cash. Subject to regulatory approvals & satisfaction of other conditions, the closing of the transaction is expected to occur in 2Q16.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$INCY {{ '2017-07-20T13:24:37+0000' | timeago}} • Announcement

$INCY said first patient has been treated in Phase 3 trial of itacitinib for the first-line treatment of patients with acute graft-versus-host disease (GVHD). GVHD is a condition that might occur after an allogeneic transplant, whereby the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign and attack the body.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$UNH {{ '2017-07-18T21:56:14+0000' | timeago}} • Webcast

In Optum segment, $UNH is focusing on three key areas for growth; strong sales pipeline of $40Bil, growing YTD sales and backlog. On MedicareAdvantage, the company expects to outperform the market in 2018 with a positive long-term outlook for the industry. $UNH also feels that the return of insurer's fee will be the single largest headwind in 2018.

$UNH {{ '2017-07-18T21:51:39+0000' | timeago}} • Webcast

Despite forgoing over $1.8Bil in revenues due to the withdrawal from the ACA individual insurance market and the health insurance tax moratorium, $UNH revenues increased nearly 9% to $40.8Bil. Health insurer also announced that the partnership with AARP will continue through at least 2025 to offer Medicare related products under AARP brand.

$UNH {{ '2017-07-18T21:48:14+0000' | timeago}} • Webcast

Health insurance giant $UNH said it served 2.5MM more people in 2Q17 vs. 2Q16, excluding the individual market. The business model of the insurer is focused on addressing the healthcare needs of consumers in areas like group Medicare Advantage, Medicaid programs in emerging markets like Brazil and established markets.

$UNH {{ '2017-07-18T21:45:28+0000' | timeago}} • Webcast

$UNH expects its stellar performance in first half to carry forward in the second half of 2017 and into 2018. On a global basis, the insurer serves 139MM people, including 126MM in the United States. UnitedHealth believes it is on target to exceed the $200Bil mark in 2017 for the first time.

$UNH {{ '2017-07-18T14:47:02+0000' | timeago}} • Announcement

$UNH's 2Q revenues increased approx. 8% crossing $50Bil. The insurer is on target to reach annual revenues of $200Bil for the first time. Total enrollment jumped 3% to 49.5MM people. Medical care ratio (MCR), a key indicator to measure financial health of insurance firms, increased 20 bps reaching 82.2%, in line with industry standards.

$UNH {{ '2017-07-18T14:46:13+0000' | timeago}} • Announcement

$UNH, the largest health insurer in US, reported stellar results in 2Q17 backed by the growth from its Optum segment. The insurance giant raised its 2017 outlook. $UNH now expects its 2017 GAAP EPS to be $9.20-9.35 and adjusted EPS to be $9.75-9.90. UnitedHealth is the first firm in its industry to report earnings every quarter.

$DGX {{ '2017-07-18T13:54:10+0000' | timeago}} • Announcement

Medical diagnostics firm $DGX has completed the acquisition of laboratory businesses Med Fusion and Clear Point. They form the basis for Quest’s first national center of excellence in precision diagnostics for oncology. The company is now a preferred provider to several organizations that are formerly owners of one or both of the acquired entities.

$UNH {{ '2017-07-18T12:59:21+0000' | timeago}} • Infographic

$UNH Unitedhealth Group, Inc. Earnings AlphaGraphics: Q2 2017 highlights

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$MGLN {{ '2017-07-13T12:33:15+0000' | timeago}} • Announcement

Health care company $MGLN has entered into a definitive agreement to acquire Senior Whole Health (SWH) for $400MM cash, inclusive of $10MM contingent payment. $MGLN anticipates paying the purchase price from the proceeds of new debt offerings. The company expects to close the transaction by end of the 1Q18.

$VRTX {{ '2017-07-13T12:31:35+0000' | timeago}} • Announcement

$VRTX announced that the Italian Medicines Agency has agreed to reimburse ORKAMBI (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis in people ages 12 and older who have two copies of the F508del mutation. Effective immediately, hundreds of eligible patients in Italy will have access to this medicine.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$HUM {{ '2017-07-12T13:21:50+0000' | timeago}} • Announcement

$HUM and Oscar Health are launching a strategic partnership to offer commercial health insurance to small businesses in a nine-county Nashville, Tenn. area.

$DXC {{ '2017-07-05T13:22:08+0000' | timeago}} • Announcement

$DXC has acquired Tribridge, an independent integrators of Microsoft Dynamics 365. The acquisition includes the Tribridge affiliate company, Concerto Cloud Services. Under the agreement, which is effective immediately, Tribridge will be known as Tribridge, a DXC Technology Company. Financial terms were not disclosed.

Recent Transcripts

ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
UNH (UnitedHealth Group Incorporated)
Tuesday, July 18 2017 - 12:45pm
DXC (DXC Technology Company)
Thursday, May 25 2017 - 9:00pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
RDNT (RadNet, Inc.)
Wednesday, May 10 2017 - 2:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
GHDX (Genomic Health Inc.)
Tuesday, May 9 2017 - 8:30pm
FMI (Foundation Medicine, Inc.)
Tuesday, May 9 2017 - 8:30pm
GTS (Triple-S Management Corporation)
Tuesday, May 9 2017 - 1:00pm
ATRS (Antares Pharma Inc.)
Tuesday, May 9 2017 - 12:30pm
CI (Cigna Corp.)
Friday, May 5 2017 - 12:30pm
MOH (Molina Healthcare, Inc.)
Thursday, May 4 2017 - 9:00pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
HUM (Humana Inc.)
Wednesday, May 3 2017 - 1:00pm
WCG (WellCare Health Plans, Inc.)
Wednesday, May 3 2017 - 12:00pm
AMRN (Amarin Corporation plc)
Wednesday, May 3 2017 - 12:00pm
KTWO (K2M Group Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
MSON (Misonix, Inc.)
Tuesday, May 2 2017 - 8:30pm
AET (Aetna Inc.)
Tuesday, May 2 2017 - 12:30pm
ZIOP (ZIOPHARM Oncology, Inc.)
Monday, May 1 2017 - 8:30pm

AlphaGraphics you may like